CYPRESS SEMICONDUCTOR CORPORATION | ||||||||
SUPPLEMENTAL FINANCIAL DATA | ||||||||
(In thousands) | ||||||||
(Unaudited) | ||||||||
| ||||||||
|
|
|
|
| ||||
|
|
Three Months Ended | ||||||
|
|
April 2, 2017 |
|
January 1, 2017 | ||||
Selected Cash Flow Data (Preliminary): |
|
|
|
| ||||
Net cash provided by operating activities |
|
$ |
25,721 |
|
|
$ |
89,787 |
|
Net cash provided by (used in) investing activities |
|
$ |
21,650 |
|
|
$ |
(19,008) |
|
Net cash used in financing activities |
|
$ |
(46,043) |
|
|
$ |
(37,262) |
|
Other Supplemental Data (Preliminary): |
|
|
|
| ||||
Capital expenditures |
|
$ |
13,772 |
|
|
$ |
11,889 |
|
Depreciation |
|
$ |
16,157 |
|
|
$ |
16,057 |
|
Payment of dividend |
|
$ |
35,537 |
|
|
$ |
35,350 |
|
Dividend paid per share |
|
$ |
0.11 |
|
|
$ |
0.11 |
|
CYPRESS SEMICONDUCTOR CORPORATION | ||||||||||||||||||||
RECONCILIATION OF GAAP FORWARDING LOOKING ESTIMATES TO NON-GAAP FORWARD LOOKING ESTIMATES | ||||||||||||||||||||
| ||||||||||||||||||||
|
|
|
|
|
|
| ||||||||||||||
|
|
Forward looking
|
|
Adjustments (B) |
|
Forward looking
| ||||||||||||||
|
|
|
|
Amortization of
|
|
Share-based compensation expense |
|
Restructuring |
|
Other
|
|
| ||||||||
Margin % |
|
38.5% - 39.5% |
|
— |
% |
|
1.0 |
% |
|
— |
% |
|
0.5 |
% |
|
40.0% - 41.0% | ||||
Diluted earnings per share |
|
$(0.13) to $(0.09) |
|
$ |
0.15 |
|
|
$ |
0.08 |
|
|
$ |
0.01 |
|
|
$ |
0.03 |
|
|
$0.14 to $0.18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|